反义整合素连接激酶寡核苷酸对上皮—间充质转型的调控及抑制喉癌转移的研究
[Abstract]:The research background and purpose: Laryngeal square cell carcinoma (LSCC) is one of the most common malignant tumors in the head and neck, and the invasion and metastasis of the tumor is one of the main causes of the death of the patients with laryngeal carcinoma. The invasion and metastasis of the laryngeal carcinoma is a multi-link and multi-step complex process. Including the biological behavior of various tumor cells such as tumor cell adhesion, movement, enzyme degradation and angiogenesis, the exact mechanism of the transfer is not yet very clear. integrin-linked kinase (ILK) is a 59KD intracellular signal protein with serine/ threonine protein The activity of ILK plays an important role not only in the normal development, but also in the process of tumor metastasis. Study effect. ILK mediates the connection of the cell to the extracellular matrix, regulates the movement of the actin cytoskeleton, participates in the formation of cell adhesion, promotes the adhesion of the tumor cells, Epithelium-Mesenchymal transition (EMT) is one of the multi-cell biological morphology. A basic physiological process. It refers to the phenomenon of the differentiation of the epithelial cells to the mesenchymal cells. In this process, the polarity of the epithelial cells is lost, the migration ability is enhanced, and at the same time, The formation and development of epithelial-derived tumors are involved in the transformation of epithelial-mesenchymal transition, especially in the case of cancer. Therefore, the role of EMT in tumor formation and invasion and metastasis and its regulation and control mechanism are becoming more and more important At present, ILK, as an induction factor for EMT, has been studied in the field of laryngeal cancer. The effect of ILK on the transformation of human laryngeal squamous cell carcinoma (Hep-2) cells and its role in the invasion and metastasis of human laryngeal squamous cell carcinoma (Hep-2) was studied by using human laryngeal squamous cell carcinoma cell line Hep-2 as the research object. Methods: The relationship between the expression of ILK and the clinicopathological factors in the clinical specimens of laryngeal squamous cell carcinoma was studied by immunocytochemical method, and the human laryngeal squamous cell carcinoma cell line Hep-2 was used as the research object, and the ILK antisense oligonucleotide was used. The effects of ILK on the expression of human laryngeal squamous cell carcinoma (Hep-2) and the expression of mesenchymal transition-related genes in human laryngeal squamous cell carcinoma (Hep-2) and its tumor invasion were studied by means of MTT, flow cytometry, Western Blot and Transwell. Results: The positive expression rate of ILK in 56 patients with laryngeal squamous cell carcinoma (66.07%) was significantly higher than that of ILK in 28 patients with carcinoma (21.43%). There was a significant difference in the expression of ILK in the patients with laryngeal carcinoma (p0.05). The expression of ILK in the Hep-2 cells of human laryngeal squamous cell carcinoma (Hep-2) and the expression of ILK in the human laryngeal squamous cell carcinoma (Hep-2) were highly correlated with the presence or absence of lymph node metastasis. The expression of ILK in human laryngeal squamous cell carcinoma (Hep-2) cells was reduced by the expression of ILK in human laryngeal squamous cell carcinoma (Hep-2). The proliferation of the cells and the increase of the apoptosis of the cells. The expression of the EMT-related genes also showed a corresponding change: the level of the expression of the mesenchymal marker Vimentin, the epithelial marker E- There was a significant increase in the expression of cadherin. The changes in the level of these genes also led to the heterogeneous adhesion of the Hep-2 cells in the human laryngeal squamous cell carcinoma. Conclusion: ILK can promote the transfer of human laryngeal squamous cell carcinoma, and the anti-sense ILK interference can induce the transformation of human laryngeal squamous cell carcinoma Hep-2 cell-derived mesenchymal-epithelial cells.
【学位授予单位】:中南大学
【学位级别】:博士
【学位授予年份】:2010
【分类号】:R739.65
【共引文献】
相关期刊论文 前10条
1 张黎;赵仲生;;胃癌淋巴结转移相关分子标志物的研究进展[J];癌症进展;2006年05期
2 陆颖霞;谷庆隆;;低温等离子射频治疗儿童鼾症的临床观察[J];北京医学;2009年04期
3 宋志强;李然伟;张明;刘禄成;魏巍;;后腹腔镜手术与开放手术治疗肾上腺嗜铬细胞瘤疗效比较[J];吉林大学学报(医学版);2012年02期
4 李清;徐涛;何培英;郝一昌;王晓峰;;整合素连接激酶对裸鼠前列腺癌的影响[J];北京大学学报(医学版);2010年04期
5 李胜水;葛风芹;江泽;许华;刘海霞;刘春在;高秀敏;;缺氧诱导因子-la和整合素连接激酶在外阴鳞状细胞癌中的表达与临床意义[J];当代医学;2010年02期
6 蓝建华;王德林;杨宗珂;李曾;;膀胱移行细胞癌中整合素连接激酶的表达及意义[J];第三军医大学学报;2009年13期
7 高娟;朱军;潘湘阳;李红彦;陈俊霞;;特异性ILK siRNA对膀胱癌移植瘤生长及p-Akt、p-GSK3β表达的影响[J];第三军医大学学报;2011年18期
8 李萍;辛晓燕;刘淑娟;宋庆贺;毛敬;;DOC2抑制对宫颈癌SiHa细胞系的生长[J];第四军医大学学报;2006年08期
9 李奇;李琛;陈巍;吕俊丽;孙静;;ILK反义寡核苷酸抗人上皮性卵巢癌移植瘤的体内实验研究[J];中国地方病防治杂志;2012年03期
10 齐秀恒;刘琪;邹庆华;;胆囊癌PTEN、COX-2表达、相互关系及其临床意义[J];南方医科大学学报;2008年05期
相关博士学位论文 前10条
1 周为军;细胞间黏附分子5在缺血缺氧环境中对PAJU细胞的保护作用及其机制的研究[D];中南大学;2011年
2 张一宁;整合素链接激酶在大鼠肝纤维化发展机制中的作用的研究[D];吉林大学;2005年
3 房晓;ILK和PKB在肺鳞癌和腺癌中的表达及意义[D];中国医科大学;2005年
4 吴昌竹;整合素连接激酶在喉鳞状细胞癌发生中的作用及其与PTEN、AKT1/PKB关系的研究[D];中国医科大学;2006年
5 周剑云;ILK在人脐带间充质干细胞向神经细胞分化中的表达变化及意义[D];河北医科大学;2008年
6 马强;ILK调控细胞间通讯蛋白参与肾脏衰老的机制研究[D];中国人民解放军军医进修学院;2009年
7 丁召;腺病毒介导的反义细胞外信号调节激酶2基因治疗抑制肾小管上皮—间充质转化并延缓大鼠移植肾肾病[D];华中科技大学;2009年
8 杨和平;ICAM-5通过ERM/PI3K/Akt信号途径减轻Aβ诱导的神经变性[D];中南大学;2009年
9 应明真;P300/CBP相关因子在肠型胃癌中的表达及功能研究[D];第二军医大学;2010年
10 李静;模拟失重致人脐静脉内皮细胞异常和红花甙修复效应的实验研究[D];第四军医大学;2009年
相关硕士学位论文 前10条
1 宋宁宁;ILK,,PI3K及PTEN蛋白在病理性瘢痕中的表达及意义[D];郑州大学;2010年
2 段方方;DOC2、rasP21、c-Fos在大肠癌中的表达及其临床意义[D];郑州大学;2010年
3 余俊隆;ILK和MMP-9在食管鳞癌组织中的表达及其意义[D];重庆医科大学;2011年
4 朱军;特异性ILK-siRNA对对膀胱癌EJ细胞侵袭和转移的影响[D];重庆医科大学;2011年
5 陈亮;miRNA沉默ILK基因对人膀胱癌BIU-87细胞增殖的影响[D];重庆医科大学;2011年
6 高双友;上皮钙粘蛋白在前列腺癌中的表达及其临床意义[D];华北煤炭医学院;2009年
7 赵满意;电挤切刀在儿童扁桃体手术中的应用[D];大连医科大学;2011年
8 陈明秋;Borrmann Ⅳ型胃癌129例临床分析[D];福建医科大学;2003年
9 吴蓉;PTEN、iNOS、COX-2与胃癌的关系及临床意义[D];重庆医科大学;2004年
10 韩文红;DOC-2在卵巢上皮性肿瘤及人卵巢癌细胞系TC-1中的表达及其对TC-1细胞增殖的影响[D];第四军医大学;2004年
本文编号:2489898
本文链接:https://www.wllwen.com/yixuelunwen/yank/2489898.html